secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2022-02-18T23:59:59+00:00
Accession:  0001193125-22-046638
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organogenesis appoints Michael J. Driscoll to board as independent director
---------------------------------------------------------------------------

- Dr. Driscoll appointed independent director effective Feb 15, 2022, expanding board to nine members.
- He will serve on audit and nominating committees; receives $72,500 annual retainer.
- Received an award of 20,547 RSUs vesting Feb 15, 2023.
- Driscoll brings 28 years in financial services and 10 years in academia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000119312522046638/0001193125-22-046638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000119312522046638/d128152d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-046638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer